Systemic Sclerosis Therapy with Iloprost: A Prospective Observational Study of 30 Patients Treated for a Median of 3 Years

@article{Bettoni2002SystemicST,
  title={Systemic Sclerosis Therapy with Iloprost: A Prospective Observational Study of 30 Patients Treated for a Median of 3 Years},
  author={Lorenzo Bettoni and Alessandro Geri and Paolo Air{\'o} and Elisabetta Danieli and Ilaria Cavazzana and Christian Antonioli and Lodovico Chiesa and Franco Franceschini and Alberto Grottolo and Alberto Zambruni and Enrico Radaeli and Roberto Cattaneo},
  journal={Clinical Rheumatology},
  year={2002},
  volume={21},
  pages={244-250}
}
Iloprost is useful in the short-term treatment of severe Raynaud’s phenomenon and ischaemic ulcers in patients with systemic sclerosis (SSc), but its long-term effects are largely unknown. The aim of this study was to report long-term outcome (median follow-up 36 months) in a prospective observational study of a cohort of 30 consecutive patients with SSc who received iloprost therapy with maintenance infusions every 3 weeks after an initial cycle of 5 consecutive days. At the end of the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 41 references

Similar Papers

Loading similar papers…